Sangamo Therapeutics, Inc.
USD0.07
+0.02 (+48.00%)
CEO
Alexander D. Macrae Ch.B
IPO Date
2000-04-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.13
Prev. Close
$0.05
Day Low
$0.06
Day High
$0.13
52W Low
$0.03
52W High
$0.77
Market Cap
$0.03B
Volume
28.50M
| 1,919 |
| $0.17 |
| 27 May 2026 | Dubois-Stringfellow Nathalie | SVP-CHIEF DEVELOPMENT OFFICER | F-InKind | Disposed | 4,036 | $0.17 |
| 27 May 2026 | Willoughby Scott B. | SVP, CHIEF LEGAL OFFICER, SECY | F-InKind | Disposed | 4,036 | $0.17 |
| 27 May 2026 | Macrae Sandy | director, officer: PRESIDENT, CEO AND DIRECTOR | F-InKind | Disposed | 12,613 | $0.17 |
| 23 Apr 2026 | Davis Gregory D | Head of Research & Technology | S-Sale | Disposed | 69,827 | $0.25 |
| 23 Apr 2026 | Dubois-Stringfellow Nathalie | SVP-CHIEF DEVELOPMENT OFFICER | S-Sale | Disposed | 345,942 | $0.26 |
| 3 Apr 2026 | Dubois-Stringfellow Nathalie | SVP-CHIEF DEVELOPMENT OFFICER | A-Award | Acquired | 800,000 | $0.26 |
| 3 Apr 2026 | Jain Nikunj | Principal Accounting Officer | A-Award | Acquired | 225,000 | $0.26 |
| 3 Apr 2026 | Davis Gregory D | Head of Research & Technology | A-Award | Acquired | 225,000 | $0.26 |